Harry Shamoon
#170,801
Most Influential Person Now
Professor Emeritus of endocrinology, diabetes and metabolism
Harry Shamoon's AcademicInfluence.com Rankings
Harry Shamoonbiology Degrees
Biology
#14508
World Rank
#18275
Historical Rank
Endocrinology
#224
World Rank
#240
Historical Rank
Download Badge
Biology
Harry Shamoon's Degrees
- Doctorate Medicine University of Medicine, Taunggyi
Why Is Harry Shamoon Influential?
(Suggest an Edit or Addition)According to Wikipedia, Harry Shamoon is Professor Emeritus of endocrinology, diabetes and metabolism at the Albert Einstein College of Medicine and Montefiore Medical Center. Education Shamoon obtained B.A. with Magna cum laude from the Columbia College in 1970 and four years later got an M.D. from the Yale School of Medicine. Following graduation, he became an intern and resident at the Jacobi Medical Center and from 1977 to 1979 worked at the Robert S. Sherwin's laboratory of Yale School of Medicine.
Harry Shamoon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hypoglycemia in diabetes. (2003) (1235)
- The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. (1999) (625)
- Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. (1999) (552)
- Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. (2005) (425)
- Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. (1995) (335)
- Reliability of blood glucose monitoring by patients with diabetes mellitus. (1984) (280)
- Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. (1981) (276)
- Implementation of Treatment Protocols in the Diabetes Control and Complications Trial (1995) (274)
- Psychological and Social Correlates of Glycemic Control (1984) (232)
- Oral Vanadyl Sulfate Improves Insulin Sensitivity in NIDDM but Not in Obese Nondiabetic Subjects (1996) (184)
- Counterregulatory adaptation to recurrent hypoglycemia in normal humans. (1991) (161)
- Lack of effect of sucralose on glucose homeostasis in subjects with type 2 diabetes. (2003) (145)
- Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. (1998) (136)
- Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. (2007) (133)
- Efficacy, Safety, and Dose-Response Characteristics of Glipizide Gastrointestinal Therapeutic System on Glycemic Control and Insulin Secretion in NIDDM: Results of two multicenter, randomized, placebo-controlled clinical trials (1997) (131)
- The influence of acute physiological increments of cortisol on fuel metabolism and insulin binding to monocytes in normal humans. (1980) (115)
- Further Defects in Counterregulatory Responses Induced by Recurrent Hypoglycemia in IDDM (1992) (102)
- Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia. (1999) (93)
- The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus. (1999) (91)
- The Pharmacological Treatment of Hyperglycemia in NIDDM (1996) (89)
- Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects. (1995) (86)
- Epinephrine-induced Hypoaminoacidemia in Normal and Diabetic Human Subjects: Effect of Beta Blockade (1980) (83)
- Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. (2002) (79)
- Self-Monitoring of Capillary Blood Glucose: Changing the Performance of Individuals with Diabetes (1985) (75)
- Incentives and barriers to retinopathy screening among African-Americans with diabetes. (1997) (74)
- Impaired Counterregulation of Hypoglycemia in Insulin-dependent Diabetes Mellitus (1983) (70)
- Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia. (1989) (69)
- Defective Epinephrine and Growth Hormone Responses in Type I Diabetes Are Stimulus Specific (1987) (65)
- Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. (1993) (64)
- Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. (2002) (64)
- Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children. (2003) (63)
- Hypoglycemia in diabetes: common, often unrecognized. (2004) (62)
- Persistent Alterations of the Autonomic Nervous System after Noncardiac Surgery (1998) (57)
- Epinephrine and the regulation of glucose metabolism: effect of diabetes and hormonal interactions. (1980) (57)
- Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus. (1994) (56)
- Assessment of documented foot examinations for patients with diabetes in inner-city primary care clinics. (1995) (54)
- Hormonal and metabolic effects of calcium channel antagonists in man. (1988) (51)
- Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma. (1991) (51)
- Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes. (2006) (49)
- Erratum: Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects (Diabetes (1996) 45 (659-666)) (1996) (47)
- Evidence for an important role of changes in rather than absolute concentrations of glucagon in the regulation of glucose production in humans. (1980) (47)
- Opioid receptor blockade improves hypoglycemia-associated autonomic failure in type 1 diabetes mellitus. (2011) (40)
- Effect of physiological hyperinsulinemia on counterregulatory hormone responses during hypoglycemia in humans. (1992) (39)
- Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group. (1997) (38)
- Physiologic hyperinsulinemia enhances counterregulatory hormone responses to hypoglycemia in IDDM. (1993) (36)
- Ophthalmic referral rates for patients with diabetes in primary-care clinics located in disadvantaged urban communities. (1995) (35)
- Selective counterregulatory hormone responses after oral glucose in man. (1982) (35)
- Counterregulation of Hypoglycemia: Skeletal Muscle Glycogen Metabolism During Three Hours of Physiological Hyperinsulinemia in Humans (1995) (35)
- Post-challenge hyperglycemia in older adults is associated with increased cardiovascular risk profile. (2009) (33)
- Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program (2012) (33)
- Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade. (2009) (32)
- Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectoris. (1982) (32)
- Human Cerebral Blood Flow and Metabolism in Acute Insulin-Induced Hypoglycemia (2005) (32)
- Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. (1994) (30)
- Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes. (1990) (29)
- Fructose amplifies counterregulatory responses to hypoglycemia in humans. (2002) (27)
- Influence of oral verapamil on glucoregulatory hormones in man. (1985) (26)
- Effects of Estrogen on Glucose Uptake by Rat Muscle 1 (1974) (26)
- Effects of physiological infusion of epinephrine in normal humans: relationship between the metabolic response and beta-adrenergic binding. (1980) (24)
- DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes (2020) (24)
- Fasting plasma insulin modulates lipid levels and particle sizes in 2- to 3-year-old children. (2003) (22)
- Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults. (2013) (20)
- Fructose normalizes specific counterregulatory responses to hypoglycemia in patients with type 1 diabetes. (2005) (18)
- Quality Assurance for Blood Glucose Monitoring in Health-Care Facilities (1991) (17)
- Opioid Receptor Blockade Prevents Exercise-Associated Autonomic Failure in Humans (2012) (16)
- Diabetes Care Needs of Hispanic Patients Treated at Inner-City Neighborhood Clinics in New York City (1995) (16)
- Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans (2017) (16)
- Magnitude of exercise-induced β-endorphin response is associated with subsequent development of altered hypoglycemia counterregulation. (2012) (16)
- Relationship of insulin secretion and glycemic response to dietary intervention in non-insulin-dependent diabetes. (1990) (16)
- Vanadyl Sulfate Does Not Enhance Insulin Action in Patients With Type 1 Diabetes (1998) (15)
- Preparedness of the CTSA's Structural and Scientific Assets to Support the Mission of the National Center for Advancing Translational Sciences (NCATS) (2012) (14)
- Developing a Multidisciplinary Model of Comparative Effectiveness Research Within a Clinical and Translational Science Award (2011) (12)
- Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects. (2001) (12)
- Effects of labetalol on perioperative stress markers and isoflurane requirements. (1991) (12)
- Assessment of long-term glycemia in type I diabetes using multiple blood glucose values stored in a memory-containing reflectometer. (1986) (11)
- Impaired glucose disposal following mild hypoglycemia in nondiabetic and type I diabetic humans. (1992) (10)
- Acute hyperglycaemic effect of anaesthetic induction with thiopentone (1993) (9)
- Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus. (2000) (9)
- Increased norepinephrine variability in patients with sleep apnea syndrome. (1995) (8)
- Hypoglycemia (1994) (8)
- Continuous glucose monitoring: the next step toward closing the loop. (2000) (7)
- β-Adrenergic blockade is more effective in suppressing adrenaline-induced glucose production in Type 1 (insulin-dependent) diabetes (1984) (7)
- Awakening from Sleep and Hypoglycemia in Type 1 Diabetes Mellitus (2007) (7)
- Increased lipid oxidation but normal muscle glycogen response to epinephrine in humans with IDDM. (1996) (7)
- Abnormal growth hormone responses to hypoglycemia and exercise in adults with type I diabetes. (1990) (6)
- Insulin response and glycemic effects of meals in non-insulin-dependent diabetes. (1990) (6)
- Rest and exercise hemodynamic and adrenergic responses to enalapril, hydrochlorothiazide, and combination treatment in patients with systemic hypertension. (1985) (6)
- Potential approaches to prevent hypoglycemia-associated autonomic failure (2017) (5)
- Pathophysiology of Diabetes (2012) (5)
- Pathophysiology of diabetes. A review of selected recent developments and their impact on treatment. (1992) (5)
- The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience (2022) (5)
- Delivery of diabetes care to low--income patients: assessment of a federally funded program. (1989) (5)
- Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure. (2020) (5)
- Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia. (1986) (4)
- Epinephrine-induced hypoaminoacidemia in man: A β-adrenergic effect (1979) (4)
- Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study (2018) (4)
- The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS) (2022) (3)
- DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes (2020) (2)
- Transforming Research Environments through Institutional Partnerships: (2010) (2)
- 115-OR: Epinephrine Contributes to Hypoglycemia-Associated Autonomic Failure (HAAF) (2019) (1)
- Counterregulatory hormone interactions in normal and diabetic man: mechanism for stress-induced diabetes (1978) (1)
- Increased adhesion of diabetic erythrocytes to the vascular endothelium in shear flow conditions (1987) (1)
- Beta-adrenergic blockade is more effective in suppressing adrenaline-induced glucose production in Type 1 (insulin-dependent) diabetes. (1984) (1)
- LABETALOLʼS EFFECTS ON CARDIOVASCULAR AND SYMPATHOADRENAL RESPONSES TO ANESTHESIA AND SURGERY (1989) (0)
- Synergistic interactions of counterregulatory hormones: a new mechanism for stress-induced diabetes (1978) (0)
- The effects of 17b-estradiol on the insulin sensitivity of rat diaphragm muscle: In vitro and in vivo studies (1974) (0)
- A135 PERIOPERATIVE CHANGES IN THE QT INTERVAL IN RESPONSE TO ANESTHETICS AND PLASMA CATECHOLAMINES (1990) (0)
- Meets learning need codes 2000 , 5190 , and 9020 ack of effect of sucralose on glucose homeostasis in ubjects with type 2 diabetes (0)
- 1767-P: Intranasal Naloxone Prevents the Development of Hypoglycemia-Associated Autonomic Failure (HAAF) in Susceptible Individuals (2020) (0)
- Diabetes management in the 1980s (1986) (0)
- Interrelationships among Components of the Metabolic Syndrome in Women Participants of the "MODELS" Study (1998) (0)
- HYPERGLYCEMIA FOLLOWING INDUCTION WITH THIOPENTAL IN HEALTHY WOMEN (1991) (0)
- Acute insulin induced hypoglycemia: Blood flow and metabolism in humans (2005) (0)
- American Journal of Medicine, August 1984, p 211-7 Reliability of blood glucose monitor ing by patients with diabetes mellitus (1985) (0)
- 58 TIME-DEPENDENT EFFECTS OF FREE FATTY ACIDS (FFA) ON GLUCOSE EFFECTIVENESS IN TYPE 2 DIABETES MELLITUS. (2004) (0)
- Opioid Receptor Blockade with Intranasal Naloxone Prevents the Development of Hypoglycemia-Associated Autonomic Failure (2018) (0)
This paper list is powered by the following services:
Other Resources About Harry Shamoon
What Schools Are Affiliated With Harry Shamoon?
Harry Shamoon is affiliated with the following schools:
